STS
GSK icon

SG Trading Solutions’s GSK GSK Stock Holding History

SG Trading Solutions’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$567K Buy
+11,567
New +$539K 0.13% 134

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SG Trading Solutions's GSK Position: Q4 2025 in Review

SG Trading Solutions opened a new position in GSK (GSK) in Q4 2025: 11,567 shares worth $567K. The stake represents 0.13% of the portfolio and ranks #134 among its holdings.

996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • SG Trading Solutions held 11,567 shares of GSK worth $567K as of Q4 2025.
  • GSK was a new SG Trading Solutions position in Q4 2025.
  • GSK made up 0.13% of SG Trading Solutions's portfolio in Q4 2025, its #134 holding.
  • 996 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on SG Trading Solutions's 13F filing for Q4 2025, filed 24 Feb 2026.